The New M&A Landscape

The M&A market is showing signs of resilience, but the rules of engagement have changed. Dealmakers must navigate a labyrinth of antitrust regulations and geopolitical sensitivities to close transactions successfully.

Heightened Regulatory Scrutiny

Antitrust enforcers globally have adopted a more aggressive stance, challenging vertical mergers and deals in technology and pharmaceutical sectors. Early engagement with regulators and robust antitrust risk assessments are now prerequisites for any significant transaction.

The Rise of Private Equity

Private equity firms continue to sit on record levels of dry powder. However, high interest rates have shifted focus from leverage-heavy buyouts to operational value creation. We are seeing more "buy-and-build" strategies and take-private transactions.

Cross-Border Complications

Geopolitical tensions and protectionist policies (such as FDI screening mechanisms) complicate cross-border deals. Thorough due diligence on national security implications is essential for international transactions.